Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial (Q42613611)
Jump to navigation
Jump to search
scientific article published on 17 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial |
scientific article published on 17 August 2011 |
Statements
1 reference
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial (English)
1 reference
1 reference
1 reference
Hagop M Kantarjian
1 reference
Gianantonio Rosti
1 reference
Rick E Blakesley
1 reference
Leif Stenke
1 reference
Carmino De Souza
1 reference
Albert Hoenekopp
1 reference
Yeow-Tee Goh
1 reference
Hirohisa Nakamae
1 reference
Neil J Gallagher
1 reference
Timothy P Hughes
1 reference
17 August 2011
1 reference
1 reference
Identifiers
1 reference